arsenic trioxide has been researched along with Hepatitis B Virus Infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakamura, Y; Taguchi, A; Tanaka, M; Tanaka, Y; Tanizawa, Y; Yujiri, T | 1 |
Chen, H; Liu, J; Liu, L; Liu, M; Shi, B; Ye, L; Yu, L; Zhang, Y | 1 |
Au, WY; Fong, BM; Hui, CK; Kwong, YL; Liu, CL; Shek, TW; Tam, S | 1 |
3 other study(ies) available for arsenic trioxide and Hepatitis B Virus Infection
Article | Year |
---|---|
Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with acute promyelocytic leukemia treated with arsenic trioxide.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Virus Activation | 2014 |
A case report of acute myeloid leukemia after liver transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow; Cytarabine; Daunorubicin; Hepatitis B; Humans; Leukemia, Myeloid, Acute; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mitoxantrone; Oxides; Tretinoin | 2013 |
Oral arsenic trioxide therapy for acute promyelocytic leukemia before and after liver transplantation for hepatitis B virus-related liver failure.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Hepatitis B; Hepatitis B virus; Humans; Leukemia, Promyelocytic, Acute; Liver Failure; Liver Transplantation; Male; Oxides; RNA, Viral; Time Factors; Transplantation, Homologous; Virus Activation | 2007 |